Physician reasons for nonpharmacologic treatment of hyperglycemia in older patients newly diagnosed with type 2 diabetes mellituss

Diabetes Therapy

Volumn 3, Issue 1, 2012, Pages 1-12

  Marrett, Elizabeth ^a,b   Zhang, Qiaoyi ^c   Kanitscheider, Claudia ^d   Davies, Michael J ^c   Radican, Larry ^c   Feinglos, Mark N ^e  

^a Global Health Outcomes Merck   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Kantar Germany   (Germany)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antihyperglycemic agents; Clinical inertia; Elderly; Non treatment; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; DIABETIC MICROANGIOPATHY; DIET THERAPY; DISEASE DURATION; DISEASE SEVERITY; DRUG INDICATION; EXERCISE; FEMALE; GENERAL PRACTITIONER; GERIATRIC CARE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; ONLINE ANALYSIS; PERCEPTION; PHYSICIAN ATTITUDE; POLYPHARMACY; PRIORITY JOURNAL; TREATMENT PLANNING; UNITED STATES;

EID: 84863929831     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-012-0005-8     Document Type: Article

References (22)

1. Sloan FA, Bethel MA, Ruiz D Jr, Shea AM, Feinglos MN. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med. 2008;168:192-9.
2. Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med. 2007;167:921-7.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 198;352:837-53.
4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-65.
5. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-89.
6. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(Suppl. 1):S11-63.
7. Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51:S265-80.
8. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-59.
9. Erwin G, Iyer S, Rajagopalan R, et al. Type 2 diabetes mellitus treatment patterns and healthcare costs in the elderly population. Dis Manag Health Outcomes. 2006;14:75-83.
10. Zhang Q, Rajagopalan S, Marrett E, Davies MJ, Radican L, Engel SS. Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes. Diabetes Obes Metab. 2012;14:149-54.
11. Pani LN, Nathan DM, Grant RW. Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%. Diabetes Care. 2008;31:386-90.
12. de Fine Olivarius N, Palmvig B, Andreasen AH, Thorgersen JT, Hundrup C. An educational model for improving diet counselling in primary care: a case study of the creative use of doctors' own diet, their attitudes to it and to nutritional counselling of their patients with diabetes. Patient Educ Couns. 2005;58:199-202.
13. Jallinoja P, Absetz P, Kuronen R, et al. The dilemma of patient responsibility for lifestyle change: perceptions among primary care physicians and nurses. Scand J Prim Health Care. 2007;25:244-9.
14. Agarwal G, Nair K, Cosby J, et al. GPs' approach to insulin prescribing in older patients: a qualitative study. Br J Gen Pract. 2008;58:569-75.
15. Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract. 2008;62:860-8.
16. Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28:2673-9.
17. van Avendonk MJ, Gorter KJ, van den DM, Rutten GE. Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands. Prim Care Diabetes. 2009;3:23-8.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.
19. Zhang Q, Marrett E, Jameson K, et al. Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study. BMC Endocr Disord. 2011;11:17.
20. Grant RW, Wexler DJ, Watson AJ, et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care. 2007;30:1448-53.
21. Hansen LJ, Olivarius NF, Siersma V, Drivsholm T, Andersen JS. Individualised treatment goals in diabetes care. Scand J Prim Health Care. 2004;22:71-7.
22. Spoelstra JA, Stolk RP, Klungel OH, et al. Initiation of glucose-lowering therapy in type 2 diabetes mellitus patients in general practice. Diabet Med. 2004;21:896-900.